BioSpace News Archive

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the first quarter ended March 31, 2023.

KaliVir Immunotherapeutics, Inc. today announced the appointment of Grant McFadden , Ph.D., to its Board of Directors.

Precision X-Ray, Inc., a global leader in cabinet X-ray irradiators, is excited to announce the launch of CellRadHD, our next generation high-dose benchtop irradiator with integrated dosimetry and dose control.

Bayer and Bicycle Therapeutics plc today announced that they have entered into a strategic collaboration agreement to discover, develop, manufacture, and commercialize Bicycle radioconjugates for multiple agreed upon oncology targets.

Seres Therapeutics, Inc. today announced that on May 3, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 19,000 shares of its common stock to four new employees, consisting of stock options to purchase an aggregate of 11,000 shares of common stock.

Kallyope , Inc. today announced that it has received $8.2 million from the Bill & Melinda Gates Foundation.

Coya Therapeutics, Inc. today announced its financial results for the first quarter ended March 31, 2023, and provided a clinical and business update.

Theralase Technologies Inc. announced today an update on its recently reported Phase II clinical study (“Study II”) interim clinical data.

Alterity Therapeutics Limited released its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 31st March 2023 (Q3 FY23).

Mirum Pharmaceuticals, Inc. announced that on May 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 20,850 shares of common stock and 10,430 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan.